trending Market Intelligence /marketintelligence/en/news-insights/trending/ryd2jezhodf3w7pjgndkyg2 content esgSubNav
In This List

Medpace's director steps down

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Medpace's director steps down

Medpace Holdings Inc. said Supraj Rajagopalan stepped down as the company's director and chairperson of the compensation committee, effective Aug. 31.

Cincinnati-based Medpace provides scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries.